Oral Acetaminophen Use for Pain Reduction in Electrophysiology Procedures
1 other identifier
interventional
200
1 country
1
Brief Summary
The investigators are purposing a study to evaluate the use of acetaminophen given prior to an electrophysiology procedure and post procedural pain control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2018
CompletedFirst Posted
Study publicly available on registry
October 10, 2018
CompletedStudy Start
First participant enrolled
February 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedJuly 2, 2019
June 1, 2019
1.3 years
August 23, 2018
June 28, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Numerical rating scale measurement of pain in response to electrophysiology procedures and change in pain over time.
A standard 0-10 numerical rating scale of pain (0=no pain, 10 = the worst possible pain) will be subjectively reported to nursing staff and recorded.
The patients pain will be recorded prior to the procedure and then every one hour post procedure for four hours. Pain will then be recorded every four hours for a total of 24 hours or patient discharge from the hospital whichever comes first.
Secondary Outcomes (1)
Additional Pain Medication
We will monitor the patients for additional doses of pain medication from the time their procedure is completed and the following 24 hours.
Study Arms (2)
Intervention Group
ACTIVE COMPARATORPatients in the intervention group with receive the study medication 1000mg acetaminophen orally one time prior to their scheduled electrophysiology procedure.
Placebo Oral Tablet
PLACEBO COMPARATORPatients in the control group will receive a placebo orally one time prior to their scheduled electrophysiology procedure.
Interventions
Intervention group will receive 1000 mg of acetaminophen
Control group will be given a placebo capsule.
Eligibility Criteria
You may qualify if:
- Age: Over 18
- Weight: Greater than 50kg
- Scheduled for an EP procedure
- Be able to take oral medications
- Provide signed written informed consent
You may not qualify if:
- Have chronic pain requiring the use of chronic pain medications including narcotic pain medications or chronic acetaminophen use greater than seven consecutive days prior to the procedure
- Known hypersensitivity to acetaminophen
- Known or suspected history of alcohol or drug abuse/dependence within the previous 2 years
- Known impaired liver function
- Active pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ascension Healthlead
Study Sites (1)
Ascension Genesys Hospital
Grand Blanc, Michigan, 48439, United States
Related Publications (4)
January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014 Dec 2;130(23):2071-104. doi: 10.1161/CIR.0000000000000040. Epub 2014 Mar 28. No abstract available.
PMID: 24682348BACKGROUNDBode K, Breithardt OA, Kreuzhuber M, Mende M, Sommer P, Richter S, Doering M, Dinov B, Rolf S, Arya A, Dagres N, Hindricks G, Bollmann A. Patient discomfort following catheter ablation and rhythm device surgery. Europace. 2015 Jul;17(7):1129-35. doi: 10.1093/europace/euu325. Epub 2014 Dec 8.
PMID: 25488958BACKGROUNDWininger SJ, Miller H, Minkowitz HS, Royal MA, Ang RY, Breitmeyer JB, Singla NK. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery. Clin Ther. 2010 Dec;32(14):2348-69. doi: 10.1016/j.clinthera.2010.12.011.
PMID: 21353105BACKGROUNDJibril F, Sharaby S, Mohamed A, Wilby KJ. Intravenous versus Oral Acetaminophen for Pain: Systematic Review of Current Evidence to Support Clinical Decision-Making. Can J Hosp Pharm. 2015 May-Jun;68(3):238-47. doi: 10.4212/cjhp.v68i3.1458.
PMID: 26157186BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Taipale, D.O.
Ascension Health
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardiology Fellow
Study Record Dates
First Submitted
August 23, 2018
First Posted
October 10, 2018
Study Start
February 8, 2019
Primary Completion
June 1, 2020
Study Completion
June 1, 2020
Last Updated
July 2, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share
No plans at this time to share IPD with other researchers